Legal entity
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention Department of Health and Aged Care, the most common co-covered peer. The 7 average consequence score is above the beat benchmark of 6.4 in the same window.
Last mentioned: Mar 20, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention Department of Health and Aged Care, the most common co-covered peer. The 7 average consequence score is above the beat benchmark of 6.4 in the same window. Source depth averages 3 original sources per story, versus 3.3 across the same-window beat baseline. Therapeutic Goods Administration (TGA) appears in 1 tracked Legal story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 47 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Therapeutic Goods Administration (TGA). Shared-story counts are live from our verified record — not editorial picks.
Implementation
New pricing structures and stricter clinical criteria for reimbursement are expected to take effect.
Subsidy Cut Announcement
Government announces plans to slash subsidies for SCS devices based on findings that they 'don't work' for many patients.
Regulatory Review
The TGA and Department of Health initiate a formal review into the clinical efficacy of spinal cord stimulators.
Rising Adverse Events
Increased reporting of 'failed back surgery syndrome' and device-related injuries in Australian hospitals.
The Australian government is moving to drastically reduce subsidies for spinal cord stimulators following evidence of severe patient injuries and a lack of clinical efficacy. This regulatory pivot marks a major shift in medical device reimbursement, prioritizing long-term safety over industry-led innovation claims.
Source: smh.com.au · theage.com.au
Therapeutic Goods Administration (TGA) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
